Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: February 2012

Aeolus Pharmaceuticals, Inc. (AOLS) to Present at the ROTH Capital Partners 24th Annual Conference

Aeolus Pharmaceuticals is focused on the development of a new class of catalytic antioxidant compounds that protects healthy tissue from the damaging effects of radiation. Aeolus’ first compound is AEOL 10150, which is being developed for oncology indications to be … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

ADA-ES, Inc. (ADES) to Present at the ROTH Capital Partners 24th Annual Conference

ADA-ES serves the coal-fueled power plant industry by offering clean coal technology and associated specialty chemicals. ADA-ES utilizes its proprietary environmental technologies and specialty chemicals to enable power plants to meet the challenges of existing and pending emission control by … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Adeona Pharmaceuticals, Inc. (AEN) to Present at the ROTH Capital Partners 24th Annual Conference

Adeona Pharmaceuticals is engaged in the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. Adeona is developing, or has partnered in the development of, product candidates to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

ACADIA Pharmaceuticals, Inc. (ACAD) to Present at the ROTH Capital Partners 24th Annual Conference

ACADIA Pharmaceuticals focuses on the use of innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA has four product candidates in clinical development, including a potential first-in-class treatment for Parkinson’s disease … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Actuate Corp. (BIRT) to Present at the ROTH Capital Partners 24th Annual Conference

Actuate is founder and co-leader of the Eclipse BIRT open source project, a premier development environment for presenting compelling data visualizations to users and an integral part of Actuate products. These products are designed to maximize end user productivity and … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Acacia Research Corp. (ACTG) to Present at the ROTH Capital Partners 24th Annual Conference

Acacia Research operates through its subsidiaries to partner with inventors and patent owners, license the patents to corporate users, and share the revenue. Acacia’s subsidiaries control more than 200 patent portfolios spanning technologies used in a wide variety of industries. … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Aastrom Biosciences, Inc. (ASTM) to Present at the ROTH Capital Partners 24th Annual Conference

Aastrom Biosciences is a biotech company engaged in developing autologous cell therapies for the treatment of severe and chronic cardiovascular diseases. The company’s clinical development programs include CLI program, which is in phase IIb clinical development for the treatment of … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Ur-Energy Inc. (URG) Completes Acquisition of Interests to Adjacent, Contiguous Acreage in Wyoming at Lost Creek Uranium Property

Today, Ur-Energy, considered by many to be North America’s premier junior uranium mining company, reported that wholly-owned subsidiary NFU Wyoming, LLC successfully completed an important asset exchange agreement with Uranium One Americas, Inc. covering certain federal unpatented mining claims, as … Continue reading

Posted in Small Cap News | Leave a comment

AxoGen, Inc. (AXGN) is “One to Watch”

AxoGen, Inc., parent company of wholly-owned operating subsidiary AxoGen Corp., is the Alachua, FL, headquartered developer of an impressive portfolio of proprietary technologies in the peripheral nerve reconstruction/regeneration space, which, through advancements like the Avance® Nerve Graft, is revolutionizing peripheral … Continue reading

Posted in Ones to Watch | Leave a comment

Alvarion Ltd. (ALVR) Unveils New 3G and LTE Mobile Data Offloading Solution

Today, Alvarion announced a new solution for Wi-Fi mobile data offloading in 3G and LTE networks that will enable a high level of service, fast connectivity, and secured Internet access. The company’s carrier-grade Wi-Fi, based on two-way Beamforming Wi-Fi technology, … Continue reading

Posted in Small Cap News | Leave a comment